Trial Profile
A Randomized, Placebo-Controlled, Double-blind, Parallel Group, Multi-centre Phase II Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Apr 2014
Price :
$35
*
At a glance
- Drugs M 516102 (Primary)
- Indications Pruritus
- Focus Therapeutic Use
- Sponsors Maruho
- 18 Apr 2014 New trial record